Australian Rotavirus Surveillance Program annual report, 2008/2009.

The Australian Rotavirus Surveillance Program together with collaborating laboratories Australia-wide, conducts a laboratory based rotavirus surveillance program. This report describes the genotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during the period 1 July 2008 to 30 June 2009, the second year of surveillance following introduction of rotavirus vaccine into the National Immunisation Program. Five hundred and ninety-two faecal samples from across Australia were examined for G and P genotype using hemi-nested multiplex reverse transcription-polymerase chain reaction assays. Of the 445 confirmed as rotavirus positive, genotype G2P[4] was the dominant type nationally, representing 50.3%, followed by genotype G1P[8] (22.5%). Genotypes G3P[8], G4P[8] and G9P[8] each represented less than 5% of circulating strains nationally. Uncommon rotavirus genotype combinations, including G1P[4] (n = 6), G4P[4] (n = 2) and single strains of G1P[6] and G3P[6] were identified during this study period. The national dominance of G2P[4] was associated with a large outbreak of severe gastroenteritis in Alice Springs in early 2009. This is the first report to describe G2P[4] as the dominant genotype nationally. Whether vaccine pressure has resulted in emergence of this genotype is not yet known.

[1]  Joanne M. Smart,et al.  Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. , 2009, The Journal of allergy and clinical immunology.

[2]  Manish M Patel,et al.  Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. , 2009, JAMA.

[3]  Manish M Patel,et al.  Rotavirus P[4]G2 in a Vaccinated Population, Brazil , 2008, Emerging infectious diseases.

[4]  L. Cuevas,et al.  Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine , 2008, Archives of Virology.

[5]  L. Cuevas,et al.  Predominance of Rotavirus P[4]G2 in a Vaccinated Population, Brazil , 2007, Emerging infectious diseases.

[6]  J. Carlin,et al.  The burden of rotavirus‐related illness among young children on the Australian health care system , 2006, Australian and New Zealand journal of public health.

[7]  R. Glass,et al.  Rotavirus and Severe Childhood Diarrhea , 2006, Emerging infectious diseases.

[8]  J. Heyse,et al.  Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.

[9]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[10]  Roger I Glass,et al.  Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. , 2005, The Journal of infectious diseases.

[11]  J. Carlin,et al.  Rotavirus infection and rates of hospitalisation for acute gastroenteritis in young children in Australia, 1993–1996 , 1998, The Medical journal of Australia.

[12]  R. Glass,et al.  Identification of group A rotavirus gene 4 types by polymerase chain reaction , 1992, Journal of clinical microbiology.

[13]  R. Glass,et al.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens , 1990, Journal of clinical microbiology.

[14]  G. Barnes,et al.  Australian Rotavirus Surveillance Program annual report, 2007/08. , 2008, Communicable diseases intelligence quarterly report.

[15]  G. Barnes,et al.  Australian Rotavirus Surveillance Program: annual report, 2006-07. , 2007, Communicable diseases intelligence quarterly report.

[16]  G. Barnes,et al.  National Rotavirus Surveillance Program annual report, 2005-06. , 2006, Communicable diseases intelligence quarterly report.

[17]  C. Kirkwood,et al.  Report of the Australian Rotavirus Surveillance Program 2003-2004. , 2004, Communicable diseases intelligence quarterly report.